Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
Emanuele Pontali, Stefano Volpi, Alessio Signori, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, Amedeo Montale, Marta Bustaffa, Alessia Angelelli, Roberta Caorsi, E. Giambruno, Nicoletta Bobbio, Marcello Feasi, Ilaria Gueli, F E Tricerri, Francesca Calautti, Elio Castagnola, Andrea Moscatelli, Gian Andrea Rollandi, Angelo Ravelli, Giovanni Cassola, Maria Pia Sormani, Marco Gattorno
Topics & Concepts
AnakinraMedicinePneumoniaMethylprednisoloneInternal medicineGlucocorticoidRetrospective cohort studyDiseaseLong-Term Effects of COVID-19COVID-19 Clinical Research StudiesKawasaki Disease and Coronary Complications